Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.17 USD | +2.48% | -0.13% | -35.08% |
23/04 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
18/04 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
Sales 2024 * | 461M 38.44B | Sales 2025 * | 526M 43.8B | Capitalization | 1.12B 93.41B |
---|---|---|---|---|---|
Net income 2024 * | -34M -2.83B | Net income 2025 * | -27M -2.25B | EV / Sales 2024 * | 2.3 x |
Net cash position 2024 * | 61.14M 5.1B | Net cash position 2025 * | 78.13M 6.51B | EV / Sales 2025 * | 1.98 x |
P/E ratio 2024 * |
-31.5
x | P/E ratio 2025 * |
-40.4
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on AtriCure, Inc.
1 day | +2.48% | ||
1 week | -0.13% | ||
Current month | -23.83% | ||
1 month | -23.83% | ||
3 months | -30.32% | ||
6 months | -30.50% | ||
Current year | -35.08% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 02/12/02 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 01/14/01 |
Chief Tech/Sci/R&D Officer | 52 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 04/19/04 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 02/12/02 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 10/16/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 509 M€ | -.--% | ||
0.03% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 23.17 | +2.48% | 380,567 |
25/24/25 | 22.61 | -1.91% | 326,849 |
24/24/24 | 23.05 | -0.52% | 419,955 |
23/24/23 | 23.17 | +2.03% | 947,750 |
22/24/22 | 22.71 | -2.11% | 684,150 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.08% | 1.12B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ATRC Stock